North China Pharmaceutical guarantees subsidiary loan, reveals broader commitments

North China Pharmaceutical Co., Ltd. has provided a new guarantee of 30 million yuan for a project loan to its wholly-owned subsidiary, North China Pharmaceutical Group Xiantai Pharmaceutical Co., Ltd. from China Development Bank's Hebei Branch. This brings the total outstanding guarantee balance for Xiantai Pharmaceutical to 125 million yuan, an amount within the 240 million yuan approved by the company's 2024 annual general meeting.

As of the announcement date, the company and its controlled subsidiaries have a total external guarantee amount of 1,539.1306 million yuan, representing 28.56% of the listed company's net assets as of the end of 2024. The total overdue external guarantee amount is 90 million yuan, stemming from a guarantee provided to Shijiazhuang Coking Group Co., Ltd.

The company assesses the risk of this new guarantee as controllable, stating it will not significantly impact daily operations or harm shareholder interests. The guarantee is intended to support Xiantai Pharmaceutical's operational and strategic development needs.